Most lately, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds into a wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts for a scavenger and isn't going to activate a next mess